NSE: FDC | BSE: 531599

Mid-range Performer

Download real time

474.65 -2.30 (-0.48%)

27.96% Fall from 52W High

239.5K NSE+BSE Volume

NSE 08 Aug, 2025 3:31 PM (IST)

7,727.8

Market Cap

Above industry Median

0.7

Beta 1Year

Very Low volatility

FDC Ltd. share price target and research reports

Name: Latest research reports of FDC Ltd. authored by Rudra Shares and Stock Brokers Ltd and published by - Trendlyne research reports.
Item: FDC Ltd.
Rating: 5
Author: Rudra Shares and Stock Brokers Ltd

Latest analyst research reports with target prices and PDF download for FDC, BSE:531599 FDC Ltd.

Search Inside the pdf :

FDC Ltd.

11 Nov 2019

474.65

-0.48%

FDC Ltd

Buy: FDC Ltd.

Rudra Shares and Stock Brokers Ltd

Forerunner in manufacturing and marketing of Oral Rehydration Salts (ORS) and Ophthalmic & First in South East Asia to offer ophthalmic formulations, using Blow-Fill-Seal (BFS) technology. FDC is a fundamentally strong company with huge cash in its balance sheet. The company has good product profile starting with Electral which is the market leader in the ORS segment. Moreover, company continues to report decent operating margins and generates sufficient free cash flow from operations every year where part has been used for buyback in the past, for...

Number of FII/FPI investors decreased from 121 to 113 in Jun 2025 qtr

FDC Ltd.

07 Aug 2018

474.65

-0.48%

FDC Ltd

Buy: FDC Ltd.

ICICI Securities Limited

Number of FII/FPI investors decreased from 121 to 113 in Jun 2025 qtr

FDC Ltd.

21 Aug 2017

474.65

-0.48%

FDC Ltd.

Buy: FDC Ltd.

Choice India

FDC Limited (Food, Drugs and Chemicals) is a fully integrated pharmaceutical company which has been in business for more than 70 years. The company is engaged in manufacturing of specialized formulations and oral rehydration salts (ORS) since 1972. The company is currently ranked 26th in India as per AWACS-AIOCD, recording a growth of 3.7% and attaining a market share of 0.89% whereas IPM (Indian Pharmaceutical markets) recorded a growth of 10.3% as per secondary sales, as of March 2017. The Company has built a visible presence across markets in Europe, USA, Asia, Africa, Latin America and Confederation of Independent States (CIS). It has...

FDC Ltd. is trading below its 30 day SMA of 490.0

FDC Ltd.

05 Dec 2016

474.65

-0.48%

Pick of the week - FDC Ltd

Buy: FDC Ltd.

HDFC Securities

BUY FDC Ltd between Rs. 192 - 218, for the Target Price of Rs. 255 - 290

FDC Ltd. is trading below its 30 day SMA of 490.0

FDC Ltd.

31 Dec 2013

474.65

-0.48%

FDC Limited

Buy: FDC Ltd.

Ashika Research

bulk drugs. The therapeutic segment consists of products such formulations, antioxidants and haematinics. But FDC is best known for its oral re-hydration salts (ORS) sold under the brand...

FDC Ltd. is trading below its 30 day SMA of 490.0

Is FDC Ltd. worth buying?

134 Votes:

Buy 80.6%

Sell 8.21%

Hold 11.19%